Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Arq Bras Cardiol ; 76(4): 268-72, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11323730

ABSTRACT

OBJECTIVE: Antihypertensive therapy with thiazides decreases coronary events in elderly patients. However, the influence of diuretics on myocardial ischemia has not been fully investigated. The aim of this study was to compare the effect of chlorthalidone and diltiazem on myocardial ischemia. METHODS: Following a randomized, double-blind, crossover protocol, we studied 15 elderly hypertensive patients aged 73.6+/-4.6 years with myocardial ischemia. All patients had angiographically documented coronary artery disease. We measured patients using 48- hour ambulatory electrocardiogram monitoring and exercise testing. After a 2-week period using placebo, patients received chlorthalidone or diltiazem for 4 weeks. RESULTS: Both treatments lowered systolic and diastolic blood pressures. The number of ischemic episodes on ambulatory electrocardiogram recordings was reduced with the use of chlorthalidone (2.5+/-3.8) and diltiazem (3.2+/-4.2) when compared with placebo (7.9+/-8.8; p<0.05). The total duration of ischemic episodes was reduced in both treatments when compared with placebo (chlorthalidone: 19.2+/-31.9min; diltiazem: 19.3+/-29.6min; placebo: 46.1+/-55.3min; p<0.05). CONCLUSION: In elderly hypertensive patients with coronary artery disease, chlorthalidone reduced myocardial ischemia similarly to diltiazem. This result is consistent with epidemiological studies and suggests that reduction of arterial blood pressure with thiazide therapy plays an important role in decreasing myocardial ischemia.


Subject(s)
Antihypertensive Agents/therapeutic use , Chlorthalidone/therapeutic use , Diltiazem/therapeutic use , Diuretics/therapeutic use , Hypertension/drug therapy , Myocardial Ischemia/drug therapy , Aged , Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Chlorthalidone/pharmacology , Coronary Disease/complications , Diltiazem/pharmacology , Diuretics/pharmacology , Double-Blind Method , Electrocardiography, Ambulatory , Exercise Test , Female , Heart Rate/drug effects , Humans , Hypertension/complications , Male , Myocardial Ischemia/etiology , Myocardial Ischemia/prevention & control
2.
Arq Bras Cardiol ; 57(4): 313-7, 1991 Oct.
Article in Portuguese | MEDLINE | ID: mdl-1824527

ABSTRACT

PURPOSE: To evaluate the effects of sublingual administration of diazepam, nifedipine, propranolol and the association of nifedipine with propranolol patients with hypertensive crisis. METHODS: Eighty patients with hypertensive crisis, DAP greater than 120 mmHg, and mean age of 54 +/- 7.4 years, 33 women and 47 men, were evaluated. The AP was measured with an aneroid sphygmomanometer, in mmHg, in orthostatic position, before and after 10, 20, 30 and 60 minutes of treatment. The heart rate in one minute was also measured at the same intervals. The patients were divided randomly into four groups and treated, respectively, with 10 mg of diazepam, 10 mg of nifedipine, 40 mg of propranolol and 10 mg of nifedipine associated with 40 mg of propranolol. RESULTS: A significant and gradual reduction of SAP and DAP were observed in all groups of patients. The percentage of reduction, after 60 minutes, for SAP was, respectively, 10.1%, 12.9%, 15.4% and 16%, and for DAP 7.7%, 11.3%, 13.6% and 13% in groups I to IV. The heart rate did not change in groups I and II, but significative reduction was observed in groups III (p = 0.002) and IV (p = 0.009). CONCLUSION: The drugs used were effective for the treatment of hypertensive crisis, and the sublingual administration is an important and easy way for their administration.


Subject(s)
Diazepam/therapeutic use , Hypertension/drug therapy , Nifedipine/therapeutic use , Propranolol/therapeutic use , Administration, Sublingual , Adult , Aged , Blood Pressure/drug effects , Drug Therapy, Combination , Female , Heart Rate/drug effects , Humans , Male , Middle Aged , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...